Optimization of media composition and culture conditions for acarbose production by Actinoplanes utahensis ZJB-08196

World Journal of Microbiology and Biotechnology

Volumn 27, Issue 12, 2011, Pages 2759-2766

  Wang, Ya Jun ^a   Liu, Li Ling ^a   Feng, Zhi Hua ^a   Liu, Zhi Qiang ^a   Zheng, Yu Guo ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Acarbose; Actinoplanes utahensis; Fermentation; Glycerol; Identification

Indexed keywords

ACARBOSE; ACTINOPLANES UTAHENSIS; CORN STEEP LIQUOR; CULTURE CONDITIONS; MEDIA COMPOSITION; MONOSODIUM GLUTAMATE; MYCELIAL GROWTH; OPTIMIZED CONDITIONS; SHAKE FLASKS; SOYBEAN MEAL; TYPE II;

BIOCHEMISTRY; FERMENTATION; GLYCEROL; IDENTIFICATION (CONTROL SYSTEMS);

OPTIMIZATION;

ACTINOPLANES UTAHENSIS; GLYCINE MAX; ZEA MAYS;

EID: 82355168910     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-011-0751-1     Document Type: Article

References (27)

1. Betina V (1994) Physiological regulation of secondary metabolism. In: Betina V (ed) Bioactive secondary metabolite of microorganisms: process in industrial microbiology. Elsevier Science, Amsterdam & New York, pp 66-80.
2. Bowers SG, Mahmud T, Floss HG (2002) Biosynthetic studies on the α-glucosidase inhibitor acarbose: the chemical synthesis of dTDP-4-amino-4, 6-dideoxy-α-d-glucose. Carbohydr Res 337(4): 297-304.
3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359(9323): 2072-2077.
4. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. J Am Med Assoc 290(4): 486-494.
5. Choi BT, Shin CS (2003) Reduced formation of byproduct component C in acarbose fermentation by Actinoplanes sp. CKD485-16. Biotechnol Prog 19(6): 1677-1682.
6. Coniff R, Krol A (1997) Acarbose: a review of US clinical experience. Clin Ther 19(1): 16-26.
7. Degwert U, Hülst R, Pape H, Herrold RE, Beale JM, Keller PJ, Lee JP, Floss HG (1987) Studies on the biosynthesis of the α-glucosidase inhibitor acarbose: valienamine, a m-C7 N unit not derived from the shikimate pathway. J Antibiot 40(6): 855-861.
8. Delorme S, Chiasson JL (2005) Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Curr Opin Pharmacol 5(2): 184-189.
9. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28(3): 350-356.
10. Frederich MA, Roger B, Robert EK, David DM, Seidman JG, John AS, Kevin S (1999) Short Protocols in Molecular Biology, 4th edn. John Wiley & Sons, New York.
11. Josse RG, Mcguire AJ, Saal GB (2006) A review of the economic evidence for acarbose in the prevention of diabetes and cardiovascular events in individuals with impaired glucose tolerance. Int J Clin Pract 60(7): 847-855.
12. Junge B, Heiker FR, Kurz J, Müller L, Schmidt DD, Wünsche C (1984) Untersuchungen zur struktur des α-d-glucosidaseinhibitors acarbose. Carbohyd Res 128(2): 235-268.
13. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9): 1414-1431.
14. Lebovitz HE (1998) α-Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev 6(2): 132-145.
15. Lee SS, Egelkrout E (1998) Studies on the α-glucosidase inhibitor acarbose in Actinoplanes sp.: glutamate is the primary source of the nitrogen in acarbose. J Antibiot 51(11): 225-227.
16. Lee SS, Sauerbrei B, Niggemann J, Egelkrout E (1997) Biosynthetic studies on the α-glucosidase inhibitor acarbose in Actinoplanes sp.: source of the maltose unit. J Antibiot 50(11): 954-961.
17. Liu ZQ, Sun ZH, Leng Y (2006) Directed evolution and characterization of a novel D-pantonohydrolase from Fusarium moniliforme. J Agric Food Chem 54(16): 5823-5830.
18. 7N aminocyclitol family of natural products. Nat Prod Rep 20(1): 137-166.
19. Mahmud T, Lee S, Floss HG (2001) The biosynthesis of acarbose and validamycin. Chem Rec 1(4): 300-310.
20. Parenti F, Coronelli C (1979) Members of the genus Actinoplanes and their antibiotics. Annu Rev Microbiol 33: 389-411.
21. Riley MD, Blizzard L (1995) Comparative validity of a food frequency questionnaire for adults with IDDM. Diabetes Care 18(9): 1249-1254.
22. Truscheit E, Frommer W, Junge B, Müller L, Schmidt DD, Wingender W (1981) Chemistry and biochemistry of microbial α-glucosidase inhibitors. Angew Chem Int Edit Engl 20(9): 744-761.
23. Wang YJ, Zheng YG, Xue YP, Wang YS, Shen YC (2011) Analysis and determination of anti-diabetes drug acarbose and its structural analogs. Curr Pharm Anal 7(1): 12-20.
24. Wei SM, Chen G, Tian W, Liu DS, Zhang YX, He JY (2008) The feeding techniques in acarbose fermentation. Chin J New Drugs 17(11): 923-926.
25. Wei SJ, Cheng X, Li H, Li KT (2010) Medium optimization for acarbose production by Actinoplanes sp. A56 using the response surface methodology. Afr J Biotechnol 9(13): 1949-1954.
26. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(5): 1047-1053.
27. Zheng YG, Shentu XP, Shen YC (2005) Inhibition of porcine small intestinal sucrase by valienamine. J Enzyme Inhib Med Chem 20(1): 49-53.